Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EBIX INC
Report date August 13, 2019 · Filed August 22, 2019 · Amendment
Section 16 reporting ended · disclosed 2019-08-22. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 2,915,981 |
Reported balance
After 2019-08-19 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-08-19 · Sale · Disposed 22,145 · Balance 2,915,981 F1: This amendment is being filed solely to correct the price of the listed transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed solely to correct the price of the listed transaction.
XBiotech Inc.
Report date February 03, 2020 · Filed February 13, 2020
Section 16 reporting ended · disclosed 2020-02-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,282 |
Reported balance
After 2020-02-03 transaction · row 1
1 source rowRow 1 · 2020-02-03 · Gift · Disposed 5,000,000 · Balance 110,282 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2020 Filed Feb 13, 2020 17:07 UTC | XBiotech Inc. XBIT · Entity 7044 | GiftCommon Stock | 5,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009318 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,282 Read SEC document |
| August 19, 2019 Filed Aug 22, 2019 15:34 UTC Amendment | EBIX INC EBIX · Entity 12698 | Salecommon stock | 22,145 | $36.20 | $801,686.65 |
DisclosureSEC source: 0001209191-19-047127 · doc4a.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915,981 F1 · price: This amendment is being filed solely to correct the price of the listed transaction. Read SEC document |
| August 19, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 22,145 | $30.20 | $668,803.36 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 6 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915,981 Read SEC document |
| August 16, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 30,000 | $35.24 | $1,057,191.00 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 5 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,938,126 Read SEC document |
| August 16, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 30,000 | $35.14 | $1,054,302.00 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 4 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,968,126 Read SEC document |
| August 15, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 65,000 | $34.41 | $2,236,617.50 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 3 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,998,126 Read SEC document |
| August 14, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 100,000 | $35.61 | $3,561,030.00 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,063,126 Read SEC document |
| August 13, 2019 Filed Aug 22, 2019 11:21 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 52,855 | $38.04 | $2,010,699.34 |
DisclosureSEC source: 0001209191-19-047076 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163,126 Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 10:36 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 1,200,000 | $8.25 | $9,900,000.00 |
DisclosureSEC source: 0001209191-19-034978 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,110,282 F1 · kind: Represents a purchase from the underwriter in the Issuer's public offering. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 16:25 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 16,426 | $7.91 | $129,929.66 |
DisclosureSEC source: 0001209191-19-016489 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,910,282 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.04, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 10:29 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 34,999 | $8.13 | $284,541.87 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 3 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,893,856 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $8.25, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · balance_after: Number is revised to include 150,000 shares which were inadvertently omitted from prior filings. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 10:29 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 5,302 | $8.19 | $43,423.38 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858,857 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.31, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2019 Filed Mar 4, 2019 10:29 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 5,273 | $8.13 | $42,869.49 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853,555 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.23, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2019 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 40,000 | $10.00 | $400,000.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 6 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698,282 Read SEC document |
| February 06, 2019 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 30,000 | $9.49 | $284,700.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 5 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658,282 Read SEC document |
| February 06, 2019 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 35,000 | $8.93 | $312,550.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 4 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,628,282 Read SEC document |
| January 02, 2019 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 900 | $5.15 | $4,635.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 3 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593,282 Read SEC document |
| December 27, 2018 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 2,200 | $4.98 | $10,956.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,592,382 Read SEC document |
| December 21, 2018 Filed Feb 14, 2019 14:38 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 4,200 | $6.24 | $26,208.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590,182 Read SEC document |
| December 11, 2018 Filed Dec 14, 2018 10:13 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 200,000 | $44.00 | $8,800,000.00 |
DisclosureSEC source: 0001209191-18-062582 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,215,981 Read SEC document |
| December 06, 2018 Filed Dec 14, 2018 10:13 UTC | EBIX INC EBIX · Entity 12698 | Salecommon stock | 10,000 | $46.00 | $460,032.00 |
DisclosureSEC source: 0001209191-18-062582 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415,981 Read SEC document |
| October 03, 2018 Filed Oct 4, 2018 11:05 UTC | EBIX INC EBIX · Entity 12698 | SaleCommon Stock | 12,800 | $77.20 | $988,160.00 |
DisclosureSEC source: 0001209191-18-054190 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,425,981 Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 13:13 UTC | EBIX INC EBIX · Entity 12698 | Disposition to issuercommon stock | 307,692 | $58.50 | $17,999,982.00 |
DisclosureSEC source: 0001209191-17-019171 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,438,781 Read SEC document |
| December 02, 2016 Filed Dec 19, 2016 11:00 UTC | EBIX INC EBIX · Entity 12698 | SalePut Option (obligation to buy) · Derivative | 100 | $1,025.80 Strike: $65.00 | $102,580.00 |
DisclosureSEC source: 0001209191-16-155783 · doc4.xml · derivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 10,000 shares Expires 2017-06-16 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.